Ialugen Plus

Silver sulfadiazine and sodium hyaluronate, the active ingredients in Ialugen Plus, are a sulfonamide antibacterial and a wound‑healing polymer presented as a topical cream for cutaneous use. It treats second‑degree and superficial third‑degree burns and other traumatic skin wounds by preventing bacterial infection and supporting tissue repair.

GNH USA supplies Ialugen Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ialugen Plus is a topical anti‑infective indicated for burn‑related skin conditions and traumatic wounds. - Second‑degree and superficial third‑degree burns: helps prevent infection and promotes healing of the damaged skin. - Traumatic skin wounds: provides antimicrobial protection while supporting tissue regeneration. - Prevention and treatment of bacterial infection in burns: reduces microbial colonisation and facilitates recovery.

Ialugen Plus may cause local and systemic adverse reactions.

Common Side Effects: - Local pain or burning sensation at the application site - Redness or erythema - Itching or mild pruritus - Mild edema or swelling - Increased wound exudate - Transient discoloration of surrounding skin

Serious or Rare Side Effects: - Allergic contact dermatitis - Systemic silver toxicity (argyria) with prolonged use - Severe hypersensitivity reactions such as Stevens‑Johnson syndrome - Necrotizing fasciitis (rare) - Anaphylaxis - Persistent ulceration or delayed wound healing

Before using Ialugen Plus, consider the following precautions: - Allergy assessment: verify no known sulfonamide or silver allergy. - Wound monitoring: observe for signs of worsening infection or delayed healing. - Contraindicated sites: avoid use on deep puncture wounds, compromised circulation, or mucous membranes. - Pediatric caution: use with care in neonates and infants, monitoring for systemic absorption. - Storage: Store at room temperature: keep in the original container, protect from light and moisture.

Ialugen Plus may interact with other medications or topical agents.

Major Interactions (Avoid): - Concurrent systemic sulfonamides (e.g., trimethoprim‑sulfamethoxazole) may increase toxicity. - Use with other silver‑containing dressings can lead to excess silver exposure. - Application with mercury‑based topical agents may cause adverse reactions.

Moderate Interactions (Monitor Closely): - Topical corticosteroids may reduce antimicrobial efficacy. - Anticoagulants (e.g., warfarin) could affect wound healing dynamics. - NSAIDs may mask pain, obscuring assessment of wound status.